248 related articles for article (PubMed ID: 17715137)
21. The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.
Tramontano E; Onidi L; Esposito F; Badas R; La Colla P
Biochem Pharmacol; 2004 May; 67(9):1751-61. PubMed ID: 15081874
[TBL] [Abstract][Full Text] [Related]
22. Pre-organized structure of viral DNA at the binding-processing site of HIV-1 integrase.
Renisio JG; Cosquer S; Cherrak I; El Antri S; Mauffret O; Fermandjian S
Nucleic Acids Res; 2005; 33(6):1970-81. PubMed ID: 15814814
[TBL] [Abstract][Full Text] [Related]
23. Disruption of the terminal base pairs of retroviral DNA during integration.
Scottoline BP; Chow S; Ellison V; Brown PO
Genes Dev; 1997 Feb; 11(3):371-82. PubMed ID: 9030689
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV-1 integrase by modified oligonucleotides derived from U5' LTR.
Snásel J; Rejman D; Liboska R; Tocík Z; Ruml T; Rosenberg I; Pichová I
Eur J Biochem; 2001 Feb; 268(4):980-6. PubMed ID: 11179964
[TBL] [Abstract][Full Text] [Related]
25. Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Arch Biochem Biophys; 1993 Feb; 300(2):756-60. PubMed ID: 8434953
[TBL] [Abstract][Full Text] [Related]
26. Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides.
Brodin P; Pinskaya M; Buckle M; Parsch U; Romanova E; Engels J; Gottikh M; Mouscadet JF
Biochemistry; 2002 Feb; 41(5):1529-38. PubMed ID: 11814346
[TBL] [Abstract][Full Text] [Related]
27. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1.
Cherepanov P; Esté JA; Rando RF; Ojwang JO; Reekmans G; Steinfeld R; David G; De Clercq E; Debyser Z
Mol Pharmacol; 1997 Nov; 52(5):771-80. PubMed ID: 9351967
[TBL] [Abstract][Full Text] [Related]
28. Probing of HIV-1 integrase/DNA interactions using novel analogs of viral DNA.
Agapkina J; Smolov M; Barbe S; Zubin E; Zatsepin T; Deprez E; Le Bret M; Mouscadet JF; Gottikh M
J Biol Chem; 2006 Apr; 281(17):11530-40. PubMed ID: 16500899
[TBL] [Abstract][Full Text] [Related]
29. Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration.
Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
PLoS One; 2009; 4(1):e4155. PubMed ID: 19127291
[TBL] [Abstract][Full Text] [Related]
30. The R262K substitution combined with H51Y in HIV-1 subtype B integrase confers low-level resistance against dolutegravir.
Cutillas V; Mesplede T; Anstett K; Hassounah S; Wainberg MA
Antimicrob Agents Chemother; 2015 Jan; 59(1):310-6. PubMed ID: 25348535
[TBL] [Abstract][Full Text] [Related]
31. Defining the DNA substrate binding sites on HIV-1 integrase.
Dolan J; Chen A; Weber IT; Harrison RW; Leis J
J Mol Biol; 2009 Jan; 385(2):568-79. PubMed ID: 19014951
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles.
Middleton T; Lim HB; Montgomery D; Rockway T; Tang H; Cheng X; Lu L; Mo H; Kohlbrenner WE; Molla A; Kati WM
Antiviral Res; 2004 Oct; 64(1):35-45. PubMed ID: 15451177
[TBL] [Abstract][Full Text] [Related]
33. Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase.
Yi J; Asante-Appiah E; Skalka AM
Biochemistry; 1999 Jun; 38(26):8458-68. PubMed ID: 10387092
[TBL] [Abstract][Full Text] [Related]
34. The metal ion-induced cooperative binding of HIV-1 integrase to DNA exhibits a marked preference for Mn(II) rather than Mg(II).
Pemberton IK; Buckle M; Buc H
J Biol Chem; 1996 Jan; 271(3):1498-506. PubMed ID: 8576144
[TBL] [Abstract][Full Text] [Related]
35. New class of HIV-1 integrase (IN) inhibitors with a dual mode of action.
Tsiang M; Jones GS; Niedziela-Majka A; Kan E; Lansdon EB; Huang W; Hung M; Samuel D; Novikov N; Xu Y; Mitchell M; Guo H; Babaoglu K; Liu X; Geleziunas R; Sakowicz R
J Biol Chem; 2012 Jun; 287(25):21189-203. PubMed ID: 22535962
[TBL] [Abstract][Full Text] [Related]
36. Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active site.
Métifiot M; Johnson BC; Kiselev E; Marler L; Zhao XZ; Burke TR; Marchand C; Hughes SH; Pommier Y
Nucleic Acids Res; 2016 Aug; 44(14):6896-906. PubMed ID: 27369381
[TBL] [Abstract][Full Text] [Related]
37. Chemical trapping of ternary complexes of human immunodeficiency virus type 1 integrase, divalent metal, and DNA substrates containing an abasic site. Implications for the role of lysine 136 in DNA binding.
Mazumder A; Neamati N; Pilon AA; Sunder S; Pommier Y
J Biol Chem; 1996 Nov; 271(44):27330-8. PubMed ID: 8910309
[TBL] [Abstract][Full Text] [Related]
38. Biochemical screening assays to identify HIV-1 integrase inhibitors.
Clynhens M; Smets A; Vereycken I; Van Loock M; Clayton R; Meersseman G; Goethals O
Methods Mol Biol; 2013; 1030():25-36. PubMed ID: 23821258
[TBL] [Abstract][Full Text] [Related]
39. Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase.
Hazuda DJ; Felock PJ; Hastings JC; Pramanik B; Wolfe AL
J Virol; 1997 Sep; 71(9):7005-11. PubMed ID: 9261430
[TBL] [Abstract][Full Text] [Related]
40. Differential assembly of Rous sarcoma virus tetrameric and octameric intasomes is regulated by the C-terminal domain and tail region of integrase.
Bera S; Pandey KK; Aihara H; Grandgenett DP
J Biol Chem; 2018 Oct; 293(42):16440-16452. PubMed ID: 30185621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
